Mankind Pharma's Stock Reaches All-Time High, Given 'Buy' Call by MarketsMOJO
Mankind Pharma's stock price has reached an all-time high on November 6th, 2024, with a 5% gain and an intraday high of Rs. 2882.75. According to MarketsMojo, the company's stock has been given a 'Buy' call, solidifying its position as a strong player in the pharmaceutical industry. Mankind Pharma's impressive performance in the past year, with a 59.02% increase in its stock price, showcases its growth and stability in the market. The company is currently trading higher than its moving averages, indicating a positive trend.
Mankind Pharma, one of the leading pharmaceutical companies in India, has reached a new milestone as its stock price touched an all-time high on November 6th, 2024. This comes as no surprise as the company has been consistently performing well in the market.
According to MarketsMOJO, a renowned stock analysis platform, Mankind Pharma's stock has been given a 'Buy' call. This further solidifies the company's position as a strong player in the pharmaceutical industry.
The stock opened today with a gain of 5% and touched an intraday high of Rs. 2882.75, outperforming the sector by 3.76%. The stock has also shown high volatility with an intraday volatility of 21.62%, calculated from the weighted average price.
Mankind Pharma's performance in the past year has been impressive, with a 59.02% increase in its stock price, compared to the Sensex's performance of 22.59%. This showcases the company's strong growth and stability in the market.
Moreover, Mankind Pharma is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its stock price.
With its consistent growth and strong performance, Mankind Pharma continues to be a top player in the pharmaceutical industry. Investors can look forward to a promising future with this largecap company.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
